Neuro-Oncology News

Young children who underwent treatment for brain tumors had lower academic readiness scores than their peers, according to results of a prospective longitudinal trial.

Sacituzumab govitecan-hziy exhibited efficacy as therapy for two traditionally difficult-to-treat populations, according to results of a window-of-opportunity trial.

An Alabama-based company announced that the FDA has granted 510(k) clearance to its cyber device and AI system, which are designed to improve efficiency and accuracy of glioblastoma care.

PHILADELPHIA — In this video, Cassie Kline, MD, MAS, discusses the results of the PNOC005 trial she presented at International Symposium on Pediatric Neuro-Oncology.

PHILADELPHIA — In this video, Cassie Kline, MD, MAS, discusses the results of the PNOC016 trial she presented at International Symposium on Pediatric Neuro-Oncology.

Bypassing the blood-brain barrier remains an obstacle for novel therapeutics. Healio spoke to Thomas Chen, MD, PhD, founder and CEO of NeOnc, to find out how a novel nasal spray formulation to treat brain cancer overcomes these challenges.

The FDA approved vorasidenib for certain patients with astrocytoma or oligodendroglioma.

PHILADELPHIA — In this video, Cassie Kline, MD, MAS, discusses the results of the FIREFLY-1 (NCT04775485) trial she presented at International Symposium on Pediatric Neuro-Oncology.

PHILADELPHIA — In this video, Cassie Kline, MD, MAS, highlights keynote addresses from International Symposium on Pediatric Neuro-Oncology.